Engineering organs

被引:142
作者
Atala, Anthony [1 ,2 ]
机构
[1] Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA
关键词
ACELLULAR MATRIX GRAFT; BIODEGRADABLE POLYMER SCAFFOLDS; SMOOTH-MUSCLE-CELLS; EMBRYONIC STEM-CELLS; IN-VITRO; URETHRAL RECONSTRUCTION; URINARY-BLADDER; COLLAGEN MATRIX; GROWTH-FACTORS; FUNCTIONAL-PROPERTIES;
D O I
10.1016/j.copbio.2009.10.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. Although stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.
引用
收藏
页码:575 / 592
页数:18
相关论文
共 181 条
[11]   IMPLANTATION IN-VIVO AND RETRIEVAL OF ARTIFICIAL STRUCTURES CONSISTING OF RABBIT AND HUMAN UROTHELIUM AND HUMAN BLADDER MUSCLE [J].
ATALA, A ;
FREEMAN, MR ;
VACANTI, JP ;
SHEPARD, J ;
RETIK, AB .
JOURNAL OF UROLOGY, 1993, 150 (02) :608-612
[12]   INJECTABLE ALGINATE SEEDED WITH CHONDROCYTES AS A POTENTIAL TREATMENT FOR VESICOURETERAL REFLUX [J].
ATALA, A ;
CIMA, LG ;
KIM, W ;
PAIGE, KT ;
VACANTI, JP ;
RETIK, AB ;
VACANTI, CA .
JOURNAL OF UROLOGY, 1993, 150 (02) :745-747
[13]   ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX WITH A CHONDROCYTE-ALGINATE SUSPENSION [J].
ATALA, A ;
KIM, W ;
PAIGE, KT ;
VACANTI, CA ;
RETIK, AB .
JOURNAL OF UROLOGY, 1994, 152 (02) :641-643
[14]   Commentary on the replacement of urologic associated mucosa [J].
Atala, A .
JOURNAL OF UROLOGY, 1996, 156 (02) :338-339
[15]  
ATALA A, 1995, J UROL, V153
[16]  
Atala Anthony, 1997, P149
[17]   SUBTOTAL CYSTECTOMY AND TOTAL BLADDER REGENERATION IN TREATMENT OF BLADDER CANCER [J].
BAKER, R ;
KELLY, T ;
TEHAN, T ;
PUTNAM, C ;
BEAUGARD, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (09) :1178-1185
[18]   Adult bone marrow stem cells for cell and gene therapies: Implications for greater use [J].
Ballas, CB ;
Zielske, SP ;
Gerson, SL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, :20-28
[19]   SYNTHESIS AND RGD PEPTIDE MODIFICATION OF A NEW BIODEGRADABLE COPOLYMER - POLY(LACTIC ACID-CO-LYSINE) [J].
BARRERA, DA ;
ZYLSTRA, E ;
LANSBURY, PT ;
LANGER, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (23) :11010-11011
[20]   NEW TREATMENT FOR URETHRAL STRICTURES [J].
BAZEED, MA ;
THUROFF, JW ;
SCHMIDT, RA ;
TANAGHO, EA .
UROLOGY, 1983, 21 (01) :53-57